NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹7.22 Cr | ₹7.61 Cr | ₹10 Cr | ₹12 Cr | ₹9.44 Cr |
What is the latest Long Term Provisions ratio of NEULAND LABORATORIES ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹7.22 Cr |
| Mar2024 | ₹7.61 Cr |
| Mar2023 | ₹10 Cr |
| Mar2022 | ₹12 Cr |
| Mar2021 | ₹9.44 Cr |
How is Long Term Provisions of NEULAND LABORATORIES Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹7.22 Cr | -5.10 | |
| Mar2024 | ₹7.61 Cr | -26.05 | |
| Mar2023 | ₹10 Cr | -13.62 | |
| Mar2022 | ₹12 Cr | 26.22 | |
| Mar2021 | ₹9.44 Cr | - | |
Compare Long Term Provisions of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹19,443.5 Cr | 0.6% | -8.3% | 9.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,626.0 Cr | -1% | -4.9% | -7.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,758.0 Cr | -1.6% | -0.4% | 9.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹130,021.0 Cr | 0.2% | 2.8% | 12.2% | Stock Analytics | |
| CIPLA | ₹122,046.0 Cr | 1% | -0.9% | -1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,086.0 Cr | 0.4% | 0.9% | -8.9% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 0.6% |
-8.3% |
9.1% |
| SENSEX | -0.4% |
-0.6% |
8.6% |
You may also like the below Video Courses